Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 4, 2012, Pages 675-686

  Zhang, Linlin ^a,b   Jiao, Min ^a   Li, Lei ^a,b   Wu, Dapeng ^a   Wu, Kaijie ^a,b   Li, Xiang ^a   Zhu, Guodong ^a   Dang, Qiang ^a   Wang, Xinyang ^a   Hsieh, Jer Tsong ^c   He, Dalin ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cancer stem cell; Chemoresistance; Prostate cancer; Stemness; Tumorsphere

Indexed keywords

DOCETAXEL; DOXORUBICIN; HERMES ANTIGEN; VINBLASTINE;

ABCG2 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BMI 1 GENE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CELL ADHESION; CELL FUNCTION; CELL RENEWAL; CONCENTRATION RESPONSE; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GLI1 GENE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR VOLUME; TUMOR XENOGRAFT; TUMORSPHERE CELL;

ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; POLYCOMB REPRESSIVE COMPLEX 1; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SPHEROIDS, CELLULAR; TAXOIDS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN; VINBLASTINE;

EID: 84863100174     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1146-2     Document Type: Article

References (52)

1. Ao A, Morrison BJ, Wang H, Lopez JA, Reynolds BA, Lu J (2011) Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments. PLoS One 6(4):e18810. doi:10.1371/ journal.pone.0018810
2. Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12(19):5615-5621. doi:10.1158/1078-0432.CCR-06-0169 (Pubitemid 44629587)
3. Bapat SA, Mali AM, Koppikar CB, Kurrey NK (2005) Stem and progenitor- like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65(8):3025-3029. doi:10.1158/ 0008-5472.CAN-04-3931 (Pubitemid 40524578)
4. Bisson I, Prowse DM (2009) WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 19(6):683-697. doi:10.1038/cr.2009.43
5. Bruggeman SW, Hulsman D, Tanger E, Buckle T, Blom M, Zevenhoven J, van Tellingen O, van Lohuizen M (2007) Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 12(4):328-341. doi:10.1016/ j.ccr.2007.08.032 (Pubitemid 47539307)
6. Cao L, Bombard J, Cintron K, Sheedy J, Weetall ML, Davis TW (2011a) BMI1 as a novel target for drug discovery in cancer. J Cell Biochem 112(10):2729-2741. doi:10.1002/jcb.23234
7. Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z (2011b) Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol 11:71. doi:10.1186/1471-230X-11-71
8. Ding XW, Wu JH, Jiang CP (2010) ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci 86(17-18):631-637. doi:10.1016/j.lfs.2010.02.012
9. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65(20):9328-9337. doi:10.1158/0008-5472.CAN- 05-1343 (Pubitemid 41508000)
10. Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1(1):34-45. doi:10.1038/ 35094009 (Pubitemid 33741879)
11. Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Takakura Y (2009) Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol 34(5):1381-1386
12. Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici P, Konda B, Wachsmann-Hogiu S, Black KL, Yu JS (2007) Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 25(7):1645-1653. doi:10.1634/stemcells.2006-0624 (Pubitemid 47121841)
13. Gilbert CA, Ross AH (2009) Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem 108(5):1031-1038. doi:10.1002/jcb. 22350
14. Gulino A, Ferretti E, De Smaele E (2009) Hedgehog signalling in colon cancer and stem cells. EMBO Mol Med 1(6-7):300-302. doi:10.1002/emmm.200900042
15. Hong SP, Wen J, Bang S, Park S, Song SY (2009) CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. Int J Cancer 125(10):2323-2331. doi:10.1002/ijc.24573
16. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics 2010. CA Cancer J Clin 60(5):277-300. doi:10.3322/caac.20073
17. Kelly K, Yin JJ (2008) Prostate cancer and metastasis initiating stem cells. Cell Res 18(5):528-537. doi:10.1038/cr.2008.50 (Pubitemid 351630948)
18. Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K (2002) The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) eZuxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8(1):22-28 (Pubitemid 34101455)
19. Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101(3):781-786. doi:10.1073/pnas.030 7618100 (Pubitemid 38121035)
20. Lang SH, Frame FM, Collins AT (2009) Prostate cancer stem cells. J Pathol 217(2):299-306. doi:10.1002/path.2478
21. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM (2007) Identification of pancreatic cancer stem cells. Cancer Res 67(3):1030-1037. doi:10.1158/0008- 5472.CAN-06-2030
22. Li H, Jiang M, Honorio S, Patrawala L, Jeter CR, Calhoun-Davis T, Hayward SW, Tang DG (2009) Methodologies in assaying prostate cancer stem cells. Methods Mol Biol 568:85-138. doi:10.1007/ 978-1-59745-280-9-7
23. Liu T, Xu F, Du X, Lai D, Zhao Y, Huang Q, Jiang L, Huang W, Cheng W, Liu Z (2010) Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1. Mol Cell Biochem 340(1-2): 265-273. doi:10.1007/s11010-010-0426-5
24. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17(2):211-215. doi:10.1038/nm.2284
25. Maitland NJ, Collins AT (2008) Prostate cancer stem cells: a new target for therapy. J Clin Oncol 26(17):2862-2870. doi:10.1200/ JCO.2007.15.1472
26. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M (2008) CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 8(8):784-804
27. Marshall GP 2nd, Reynolds BA, Laywell ED (2007) Using the neurosphere assay to quantify neural stem cells in vivo. Curr Pharm Biotechnol 8(3):141-145 (Pubitemid 47009481)
28. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106-110. doi:10.1038/nature05372 (Pubitemid 46067310)
29. Olsson E, Honeth G, Bendahl PO, Saal LH, Gruvberger-Saal S, Ringner M, Vallon-Christersson J, Jonsson G, Holm K, Lovgren K, Ferno M, Grabau D, Borg A, Hegardt C (2011) CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer 11(1):418. doi:10.1186/1471-2407-11-418
30. Orian-Rousseau V (2010) CD44, a therapeutic target for metastasising tumours. Eur J Cancer 46(7):1271-1277. doi:10.1016/j.ejca. 2010.02.024
31. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG (2006) Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25(12):1696-1708. doi:10.1038/ sj.onc.1209327
32. Pfeiffer MJ, Schalken JA (2010) Stem cell characteristics in prostate cancer cell lines. Eur Urol 57(2):246-254. doi:10.1016/j.eururo. 2009.01.015
33. Pienta KJ, Bradley D (2006) Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res 12(6):1665-1671. doi:10.1158/1078-0432.CCR-06-0067
34. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65(13):5506-5511. doi:10.1158/ 0008-5472.CAN-05-0626 (Pubitemid 40911148)
35. Rappa G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, Fodstad O, Lorico A (2008) Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp Cell Res 314(10):2110-2122. doi:10.1016/j.yexcr.2008.03.008
36. Rich JN, Bao S (2007) Chemotherapy and cancer stem cells. Cell Stem Cell 1(4):353-355. doi:10.1016/j.stem.2007.09.011 (Pubitemid 47506543)
37. Ruizi Altaba A, Mas C, Stecca B (2007) The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol 17(9):438-447. doi:10.1016/j.tcb.2007.06.007 (Pubitemid 47505310)
38. Sharom FJ (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9(1):105-127. doi:10.2217/14622416.9.1.105 (Pubitemid 351560534)
39. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821-5828 (Pubitemid 37187480)
40. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432(7015):396-401. doi:10.1038/nature03128 (Pubitemid 39551674)
41. Song Z, Yue W, Wei B, Wang N, Li T, Guan L, Shi S, Zeng Q, Pei X, Chen L (2011) Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. PLoS One 6(3):e17687. doi:10.1371/journal.pone. 0017687
42. Su YJ, Lai HM, Chang YW, Chen GY, Lee JL (2011) Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 30(15):3186-3199. doi:10.1038/emboj.2011.211emboj2011211
43. Takebe N, Harris PJ, Warren RQ, Ivy SP (2011) Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol 8(2):97-106. doi:10.1038/nrclinonc.2010.196
44. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755-768. doi:10.1038/nrc2499
45. Wang X, Venugopal C, Manoranjan B, McFarlane N, O'Farrell E, Nolte S, Gunnarsson T, Hollenberg R, Kwiecien J, Northcott P, Taylor MD, Hawkins C, Singh SK (2011) Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells. Oncogene. doi:10.1038/onc.2011.232onc2011232
46. Wicha MS (2006) Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res 12(19):5606-5607. doi:10.1158/1078-0432.CCR-06-1537 (Pubitemid 44629584)
47. Yu CC, Lo WL, Chen YW, Huang PI, Hsu HS, Tseng LM, Hung SC, Kao SY, Chang CJ, Chiou SH (2011) Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells. J Oncol 2011, art no 609259. doi:10.1155/2011/609259
48. Zen Y, Fujii T, Yoshikawa S, Takamura H, Tani T, Ohta T, Nakanuma Y (2007) Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol 170(5):1750-1762. doi:10.2353/ajpath.2007.060798 (Pubitemid 47339318)
49. Zhang Y, Li B, Ji ZZ, Zheng PS (2010) Notch1 regulates the growth of human colon cancers. Cancer 116(22):5207-5218. doi:10.1002/ cncr.25449
50. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, Munchhof M, VanArsdale T, Beachy PA, Reya T (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458(7239):776-779. doi:10.1038/nature07737
51. Zheng X, Shen G, Yang X, Liu W (2007) Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 67(8):3691-3697. doi:10.1158/0008-5472.CAN-06-3912 (Pubitemid 46762154)
52. Zhong Y, Guan K, Guo S, Zhou C, Wang D, Ma W, Zhang Y, Li C, Zhang S (2010) Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Cancer Lett 299(2):150-160. doi:10.1016/j.canlet.2010.08.013